Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
A group of researchers from Chinese Academy of Sciences and Peking University Third Hospital has developed a new type of...
China has approved the first domestically developed, long-acting injectable HIV drug Albuvirtide, which could be a boon ...
Singapore- Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorder...
Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of...
P-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 Ju...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Xynomic Pharma, a clinical stage US-China oncology drug development company, recently announced that it has complete...
SenseTime Group has raised $620 million at a valuation of more than $4.5 billion just months after scoring a similar amo...
Gilead Sciences, Inc. has announced that the China Drug Administration (CDA) has approved Epclusa for the treatment of a...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Chinese e-commerce giant Alibaba Group Holding Ltd will inject some of its online pharmacy business into a listed unit i...
Shuwen Biotech Co. Ltd., an emerging leader in innovative diagnostic products and services has signed a partnership agre...
Luye Pharma Group recently announced their acquisition of AstraZeneca's core CNS products - Seroquel and Seroquel XR. As...
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, recently announced acquisition of Shan...
China's WuXi Biologics, a leading global open-access biologics technology platform recently announced pla...
Brii Bio, a startup committed to serving patients' needs and improving public health in China, recently announced its la...
Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences (NLFS) has announced the closing of Pivotal bioVen...
China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Ke...
Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Shanghai Pharmaceuticals Holding Co. Ltd., a leading p...
Grail, a Hong Kong-US oncology diagnostics company, recently announced a $300 million C financing. Ally Bridge Group led...
Splendris International Limited, an affiliate of Shenzhen Salubris Pharmaceuticals Co Ltd., a multi-national leader in t...
China has created the world's first medical instrument that can induce, culture and screen stem cells automatically, ben...
Mason Group Holdings Limited announced the merger between its subsidiary Reproductive Healthcare and ...
Cuba and China have expanded their biotechnology cooperation with the signing of another memorandum of understanding for...
